Pars plana placement of Ahmed g l a u c o m a va l ve t u b e t h r o u g h sclerotomy port in refractory glaucoma: A novel surgical technique
Glaucoma drainage devices (GDDs) with tube placed in sulcus, or vitreous cavity are mainstay of management in eyes with disorganized anterior segment due to prior surgeries, like penetrating keratoplasty (PK), or a disease process itself such as neovascular glaucoma. [1, 2] However, pars plana vitrectomy (PPV) done as an adjunct procedure has risks of sclerotomy related complications which could potentially increase by making an additional port for AGV tube insertion. [3] [4] [5] [6] [7] We showcase a novel technique of combining hybrid 20-25 gauge (G) PPV with placement of Ahmed glaucoma valve (AGV; model P7, New World Medical Inc, Rancho Cucamonga, CA, USA) tube through a 25G sclerotomy.
Case Report
A 34-year-old male presented with best-corrected visual acuity (BCVA) of 20/630 in left eye (OS) and an intraocular pressure (IOP) of 40 mmHg on maximum medical therapy (MMT). The previous surgical history included cataract surgery with intraocular lens (IOL) implant, PK with IOL explant, and trabeculectomy. OS showed hazy graft, aphakia with 360° peripheral anterior synechiae with superior 200° of perilimbal fibrosis [ Fig. 1 ]. B-scan (OS) revealed total posterior vitreous detachment, attached retina with disc cupping. His right eye (OD) was absolute.
One-eyed status with poor IOP control on MMT necessitated an urgent surgical plan. Hence, AGV implantation with PPV with tube in vitreous cavity was planned. An informed written consent was obtained from the patient.
Surgical technique
Following peribulbar anesthesia and corneal traction suture, a fornix-based conjunctival flap was created in superior temporal quadrant (STQ) and Tenon's capsule dissected posteriorly. After priming, AGV plate was anchored to the sclera with 9-0 nylon (Aurolon, Aurolab, Madurai, India) sutures.
Limited conjunctival peritomy was done in infero-temporal quadrant (ITQ). A sclerotomy was made 3 mm behind the limbus using a 20G MVR blade and a 20G infusion cannula was fixed with 6-0 polyglactin suture (Vicryl, Johnson and Johnson, Aurangabad, India) in a mattress fashion. The 25G sclerotomy at STQ was made 4 mm behind limbus and was directed perpendicular to sclera [ Fig. 2a ]. Sclerotomy in the supero-nasal quadrant (SNQ) was bi-planar and beveled. A hybrid 20-25G PPV was performed. After a thorough vitreous base excision, the SNQ port was closed with 6-0 polyglactin suture. The tube was trimmed, bevel up, to an intravitreal length of 6 mm and inserted through the 25 G sclerotomy port in STQ [ Fig. 2b ]. It was fixed to the sclera and covered with a This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
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Discussion
The advent of pars plana placement of GDD tube has enhanced the surgery's success rate in recalcitrant glaucomas. [5] Prior or concurrent PPV is done to facilitate tube entry and avoid its blockage by vitreous. But the pars plana incision made for vitrectomy incites fibro-vascular proliferation (FVP) similar to a scleral wound after perforating injuries and may be attributed to exaggerated wound healing. [5, 7] The complications have been studied using ultrasound bio-microscopy and may range from a limited fibro-vascular in-growth at the sclerotomy site to extensive vitreous incarceration and anterior hyaloidal FVP, leading to tractional retinal or choroidal detachments. [3, 7, 8] 
Conclusion
We propose this technique as a simple modification of pars plana tube insertion to minimize the number of entry wounds, and hence the associated complications. It is a potential option in the cases of complex glaucomas needing GDD without compromising on the surgical outcome.
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Rheumatoid factor versus anti -cyclic citrullinated peptide antibody as screening tool for rheumatoid arthritis in an ophthalmic clinic
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Patients with moderate to severe dry eyes are often screened at the Dry Eye Clinic to rule out connective tissue diseases. Rheumatoid factor (RF) is one of the screening tools to rule out rheumatoid arthritis (RA). Patients who turn out positive for the RF are often subjected to anti-CCP antibody evaluation for confirmation of disease. This article tries to highlight 3 cases of negative and anti-CCP antibody positive cases which presented to the ophthalmic clinic, unaware of their systemic status. Though RF is the cheapest modality to screen for RA, it is not always a reliable marker. One should order anti-CCP antibody for patients where suspicion is high, despite RF being normal.
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Dry eye disease has always been an area of interest, as far as its etiology, adequate and targeted treatment is concerned. Altered ocular surface milieu can often be because of local factors contributing to dryness, however systemic factors should also be evaluated for. RA is one such systemic etiology causing dry eyes. RA can cause spectrum of ocular manifestations from keratoconjunctivitis sicca to scleritis, sclerokeratitis, peripheral ulcerative keratitis. [1] Known cases of RA are often looked for any ocular complications, however reverse referral from an ophthalmic clinic to a rheumatologist is very less often seen. Lack of awareness about the widespread prevalence of disease could be an important cause of non-referral.
There are various clinical signs, symptoms and serological tests available to diagnose the disease. The markers like RF and anti-CCP are said to have good sensitivity and specificity.
Patients with moderate to severe dry eyes are often screened at ophthalmic clinic (dry eye clinic) to rule out connective tissue diseases. At our clinic all patients with moderate to severe dry eyes (as per Dry Eye Disease grading scheme-DEWS 2007), dry eyes not responding to the conservative treatment with lubricants or associated with clinically evident systemic features were evaluated for systemic diseases. A detailed history is taken. All patients in dry eye clinic undergo detailed slit lamp examination to look for any lid or adnexal abnormality responsible for dry eye. Tear break-up time, observation of ocular surface staining patterns and Schirmers are done sequentially. We have also incorporated meibography as a workup tool in dry eye clinic.
RF is one of the screening tools to rule out RA. Patients who turn out positive for the RF are often subjected to anti-CCP antibody evaluation for confirmation of disease. The sensitivity and specificity of anti-CCP reactivity for RA patients diagnosed based on American College of Rheumatology criteria were detected as 73.5% and 100%, respectively. [2] Does that mean that cases which are negative for RF cannot have positive anti-CCP antibody? This article tries to highlight three cases of RF negative and anti-CCP antibody positive cases which presented to the ophthalmic clinic, unaware of their systemic status.
Case 1
A 60-year-old female presented to the clinic with complaints of photophobia and decreased vision for 1 month. Visual acuity in RE was 20/1200 whereas that in LE was CFCF. The Schirmers value were 8 mm and 5 mm for the right and left eye, respectively. The patient attributed the symptoms to the cataract, and wanted to get operated for it. On examination LE had diffuse superficial punctate keratitis (SPK) [ Fig. 1 ], whereas RE had filamentary keratitis. Both eyes had immature Cite this article as: Singh P, Kumar A, Chandra P. Rheumatoid factor versus anti -cyclic citrullinated peptide antibody as screening tool for rheumatoid arthritis in an ophthalmic clinic. Indian J Ophthalmol 2020;68:236-8.
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